Buy 2 get 1 free — everything calculated at checkout
1976

Analogue-based Drug Discovery II

$32.00 Lowest price online — guaranteed

Price comparison

Publisher / Official store
$110.00
Our store
$32.00

Buy 2, get 1 free. Everything is calculated automatically at checkout.

Enter a valid email at checkout. Your ebook download link is sent to the email address you provide — double-check it before completing your order.

30-day money-back guarantee. File issue? We replace it or refund you — no questions asked.

IMPORTANT

Digital product — no physical item will be shipped

You'll receive a PDF download link by email immediately after checkout.

Can't find the ebook you're looking for?

Send us the book cover image via the live chat on our website and we'll request it for you. Estimated response time: 10 minutes.

Book details

Format
PDF — instant download
Language
English

About this book

⚠️📚THIS ISN'T A PHYSICAL BOOK!

Born out of a project of the IUPAC's committee on Medicinal Chemistry and Drug Development, this reference addresses past and current strategies for successful drug analog development, extending the previously published volume by nine new analog classes and eight case studies. Like its precursor, this volume also contains a general section discussing universally applicable strategies for analog discovery and development. Spanning a wide range of therapeutic fields and chemical classes, the two volumes together constitute the first systematic approach to drug analog development. Of interest to virtually every researcher working in drug discovery and pharmaceutical chemistry.

About the Author

Janos Fischer is a Senior Research Scientist at Richter Plc., Budapest, Hungary. He received his MSc and PhD degrees in organic chemistry from the Eotvos University of Budapest under Professor A. Kucsman. Between 1976 and 1978, he was a Humboldt Fellow at the University of Bonn under Professor W. Steglich. He has worked at Richter Plc. since 1981 where he participated in the research and development of leading cardiovascular drugs in Hungary. His main interest is analogue based drug discovery. He is the author of some 100 patents and scientific publications. In 2004, he was elected as a Titular member of the Chemistry and Human Health Division of IUPAC. He received an honorary professorship at the Technical University of Budapest. C. Robin Ganellin studied Chemistry at London University, receiving a PhD in 1958 under Professor Michael Dewar, and was a Research Associate at MIT with Arthur Cope in 1960. He then joined Smith Kline & French Laboratories in the UK and was one of the co inventors of the revolutionary drug, cimetidine (also known as Tagamet). In 1986, he was made a Fellow of the Royal Society and appointed to the SK&F Chair of Medicinal Chemistry at University College London, where he is now Professor Emeritus of Medicinal Chemistry. Professor Ganellin is co inventor of over 160 patents and has authored over 260 scientific publications. He was President of the Medicinal Chemistry Section of the IUPAC and is Chairman of the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.

Author János Fischer (Editor), C. Robin Ganellin (Editor)
ISBN-13 9783527632121
Publisher Wiley
Publication Date 08/24/2010
Page Count 564 pages

Why buy from us

  • 100% Authorised by publisher — licensed copy, never pirated
  • –84% Less than Amazon Kindle — lowest price guaranteed
  • Instant PDF delivered the moment your payment clears, 24/7
  • Full Complete edition — every chapter, no missing pages
Secure Checkout
Instant Download
24/7 Support

You may also like